Micelles of Progesterone for Topical Eye Administration: Interspecies and Intertissues Differences in Ex Vivo Ocular Permeability
- Supplementary File 1:
PDF-Document (PDF, 507 KiB)
Alambiaga-Caravaca, A.M.; Calatayud-Pascual, M.A.; Rodilla, V.; Concheiro, A.; López-Castellano, A.; Alvarez-Lorenzo, C. Micelles of Progesterone for Topical Eye Administration: Interspecies and Intertissues Differences in Ex Vivo Ocular Permeability. Pharmaceutics 2020, 12, 702. https://doi.org/10.3390/pharmaceutics12080702
Alambiaga-Caravaca AM, Calatayud-Pascual MA, Rodilla V, Concheiro A, López-Castellano A, Alvarez-Lorenzo C. Micelles of Progesterone for Topical Eye Administration: Interspecies and Intertissues Differences in Ex Vivo Ocular Permeability. Pharmaceutics. 2020; 12(8):702. https://doi.org/10.3390/pharmaceutics12080702
Chicago/Turabian StyleAlambiaga-Caravaca, Adrián M., María A. Calatayud-Pascual, Vicent Rodilla, Angel Concheiro, Alicia López-Castellano, and Carmen Alvarez-Lorenzo. 2020. "Micelles of Progesterone for Topical Eye Administration: Interspecies and Intertissues Differences in Ex Vivo Ocular Permeability" Pharmaceutics 12, no. 8: 702. https://doi.org/10.3390/pharmaceutics12080702